普瑞眼科
(301239)
| 流通市值：35.09亿 | | | 总市值：74.17亿 |
| 流通股本：7078.95万 | | | 总股本：1.50亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,136,699,863.8 | 1,420,361,520.54 | 675,882,973.16 | 2,717,873,370.9 |
| 营业收入 | 2,136,699,863.8 | 1,420,361,520.54 | 675,882,973.16 | 2,717,873,370.9 |
| 二、营业总成本 | 2,058,379,113.42 | 1,329,008,871.12 | 636,079,700.34 | 2,417,543,217.55 |
| 营业成本 | 1,292,699,357.3 | 833,931,160.12 | 401,898,789.1 | 1,522,034,985.73 |
| 税金及附加 | 5,579,082.07 | 3,894,944.43 | 1,261,475.64 | 6,425,121.78 |
| 销售费用 | 380,124,297.57 | 238,232,687.14 | 110,660,221.97 | 448,608,343.37 |
| 管理费用 | 313,459,703.55 | 207,656,306.06 | 101,727,180.35 | 364,779,038.68 |
| 研发费用 | 4,878,194.72 | 4,315,984.56 | 2,410,662.58 | 11,033,602.57 |
| 财务费用 | 61,638,478.21 | 40,977,788.81 | 18,121,370.7 | 64,662,125.42 |
| 其中:利息费用 | 65,415,378.64 | 43,576,273.66 | 20,618,729.82 | 74,668,237.7 |
| 其中:利息收入 | - | 5,724,643.2 | 4,134,359.65 | 17,161,759.32 |
| 加:公允价值变动收益 | 957,667.21 | 364,749.39 | - | 101,593.07 |
| 加:投资收益 | 1,293,828.4 | 2,191,950.29 | 583,182.02 | 78,187,114.17 |
| 资产处置收益 | 7,529,705.83 | 381,728.4 | -16,527.54 | 57,736.49 |
| 资产减值损失(新) | -2,499,158.4 | -1,688,750.65 | -100,594.1 | -1,775,055.82 |
| 信用减值损失(新) | 252,090.63 | -804,370.33 | -629,680.23 | -5,004,719.43 |
| 其他收益 | 12,419,883.32 | 9,763,864.81 | 1,715,944.42 | 14,111,686.69 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 98,274,767.37 | 101,561,821.33 | 41,355,597.39 | 386,008,508.52 |
| 加:营业外收入 | 1,038,426.23 | 654,459.1 | 82,910.59 | 867,019.05 |
| 减:营业外支出 | 25,631,575.73 | 13,498,995.97 | 4,460,961.6 | 24,641,898.97 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 73,681,617.87 | 88,717,284.46 | 36,977,546.38 | 362,233,628.6 |
| 减:所得税费用 | 50,835,668.99 | 40,882,712.96 | 17,934,906.28 | 84,228,022.99 |
| 六、净利润 | 22,845,948.88 | 47,834,571.5 | 19,042,640.1 | 278,005,605.61 |
| 持续经营净利润 | 22,845,948.88 | 47,834,571.5 | 19,042,640.1 | 278,005,605.61 |
| 归属于母公司股东的净利润 | 15,841,198.32 | 43,294,484.53 | 16,924,936.43 | 267,913,456.76 |
| 少数股东损益 | 7,004,750.56 | 4,540,086.97 | 2,117,703.67 | 10,092,148.85 |
| (一)基本每股收益 | 0.11 | 0.29 | 0.11 | 1.79 |
| (二)稀释每股收益 | 0.11 | 0.29 | 0.11 | 1.79 |
| 八、其他综合收益 | - | - | - | -1,134.78 |
| 归属于母公司股东的其他综合收益 | - | - | - | -1,134.78 |
| 九、综合收益总额 | 22,845,948.88 | 47,834,571.5 | 19,042,640.1 | 278,004,470.83 |
| 归属于母公司股东的综合收益总额 | 15,841,198.32 | 43,294,484.53 | 16,924,936.43 | 267,912,321.98 |
| 归属于少数股东的综合收益总额 | 7,004,750.56 | 4,540,086.97 | 2,117,703.67 | 10,092,148.85 |
| 公告日期 | 2024-10-30 | 2024-08-28 | 2024-04-24 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |